Levitt JE, Hedlin H, Duong S, Lu D, et al. Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial. Clin Infect Dis 2023 Mar 30:ciad187. doi: 10.1093.
PMID: 36996150